Drug
DS-1040 clinical trials
Also written DS-1040b.
- studies test it
- 6
- open now
- 0
- in phase 3
- 0
- first study started
- 2014
How studies write it
Studies that test it under each name
Development codes
Studies by the year they started
6 studies that test it; most in 2015 (2)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses DS-1040 is read from its arms, and is right about nine times in ten.
Testing it · 6
- Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary EmbolismCompletedPhase 1/2Daiichi SankyoNCT02923115Written as DS-1040b
- Safety of DS-1040b in Acute Ischemic Stroke Patients Treated With ThrombectomyCompletedNot applicableDaiichi Sankyo Co., Ltd.NCT03198715Written as DS1040b
- Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b in Subjects With Acute Ischemic StrokeCompletedPhase 1/2Daiichi SankyoNCT02586233Written as DS-1040b
- DS1040b/Aspirin Drug/Drug Interaction StudyCompletedPhase 1Daiichi SankyoNCT02071004Written as DS-1040b
- Phase 1 Study to Evaluate the Safety and Tolerability of DS-1040b IV Infusion With Clopidogrel in Healthy SubjectsCompletedPhase 1Daiichi SankyoNCT02560688Written as DS-1040b
- Study of the Effects of Ethnicity on the Pharmacokinetics, Pharmacodynamics and Safety of DS-1040bCompletedPhase 1Daiichi SankyoNCT02647307Written as DS-1040b
Codes
What other systems call DS-1040 · ClinicalTrials.gg INT015127
- UNII (FDA) 5UQB96OW76DS-1040One source FDA
- NCI Thesaurus C148637TAFIa Inhibitor DS-1040bOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 5UQB96OW76 | DS-1040 | One source FDA |
| NCI Thesaurus | C148637 | TAFIa Inhibitor DS-1040b | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.